Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $55.43 million. The enterprise value is $56.77 million.
| Market Cap | 55.43M |
| Enterprise Value | 56.77M |
Important Dates
The last earnings date was Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 34.64 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Shares Outstanding | 34.64M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 17.92% |
| Owned by Institutions (%) | 42.25% |
| Float | 24.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.10 |
| Forward PS | 1.08 |
| PB Ratio | 2.74 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.87, with a Debt / Equity ratio of 1.91.
| Current Ratio | 5.87 |
| Quick Ratio | 4.71 |
| Debt / Equity | 1.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.30 |
Financial Efficiency
Return on equity (ROE) is -78.00% and return on invested capital (ROIC) is -35.59%.
| Return on Equity (ROE) | -78.00% |
| Return on Assets (ROA) | -33.60% |
| Return on Capital (ROIC) | -35.59% |
| Revenue Per Employee | $200,202 |
| Profits Per Employee | -$90,500 |
| Employee Count | 252 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.77 |
Taxes
| Income Tax | -112,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.42% in the last 52 weeks. The beta is 1.10, so Apyx Medical's price volatility has been similar to the market average.
| Beta (1Y) | 1.10 |
| 52-Week Price Change | -73.42% |
| 50-Day Moving Average | 1.48 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 56.82 |
| Average Volume (30 Days) | 157,609 |
Short Selling Information
The latest short interest is 540,335, so 1.56% of the outstanding shares have been sold short.
| Short Interest | 540,335 |
| Short Previous Month | 371,128 |
| Short % of Shares Out | 1.56% |
| Short % of Float | 2.16% |
| Short Ratio (days to cover) | 6.27 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $50.45 million and -$22.81 million in losses. Loss per share was -$0.66.
| Revenue | 50.45M |
| Gross Profit | 32.14M |
| Operating Income | -20.96M |
| Pretax Income | -22.92M |
| Net Income | -22.81M |
| EBITDA | -18.51M |
| EBIT | -19.28M |
| Loss Per Share | -$0.66 |
Balance Sheet
The company has $37.28 million in cash and $38.63 million in debt, giving a net cash position of -$1.34 million or -$0.04 per share.
| Cash & Cash Equivalents | 37.28M |
| Total Debt | 38.63M |
| Net Cash | -1.34M |
| Net Cash Per Share | -$0.04 |
| Equity / Book Value | 20.25M |
| Book Value Per Share | 0.58 |
| Working Capital | 51.37M |
Cash Flow
In the last 12 months, operating cash flow was -$9.71 million and capital expenditures $6.81 million, giving a free cash flow of -$2.90 million.
| Operating Cash Flow | -9.71M |
| Capital Expenditures | 6.81M |
| Free Cash Flow | -2.90M |
| FCF Per Share | -$0.08 |
Margins
Gross margin is 63.70%, with operating and profit margins of -41.54% and -45.20%.
| Gross Margin | 63.70% |
| Operating Margin | -41.54% |
| Pretax Margin | -45.43% |
| Profit Margin | -45.20% |
| EBITDA Margin | -36.70% |
| EBIT Margin | -38.21% |
| FCF Margin | -5.75% |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.13% |
| Shareholder Yield | -0.13% |
| Earnings Yield | -41.14% |
| FCF Yield | -5.23% |
Analyst Forecast
The average price target for Apyx Medical is $6.17, which is 285.63% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.17 |
| Price Target Difference | 285.63% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 14.19% |
| EPS Growth Forecast (5Y) | -37.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Apyx Medical has an Altman Z-Score of 0.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.12 |
| Piotroski F-Score | 2 |